Search Results - "Anders, Robert J." :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Principal Results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) Trial

Principal Results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) Trial

by Black, Henry R, Elliott, William J, Grandits, Gregory, Grambsch, Patricia, Lucente, Tracy, White, William B, Neaton, James D, Grimm, Jr, Richard H, Hansson, Lennart, Lacourcière, Yves, Muller, James, Sleight, Peter, Weber, Michael A, Williams, Gordon, Wittes, Janet, Zanchetti, Alberto, Anders, Robert J
Published in JAMA : the journal of the American Medical Association (23.04.2003)

Get full text

Journal Article

Oral glycoprotein IIb/IIIa inhibition with orbofiban in patients with unstable coronary syndromes (OPUS-TIMI 16) trial

Oral glycoprotein IIb/IIIa inhibition with orbofiban in patients with unstable coronary syndromes (OPUS-TIMI 16) trial

by CANNON, C. P, MCCABE, C. H, ALEXANDER, J. C, SKENE, A, BRAUNWALD, E, WILCOX, R. G, LANGER, A, CASPI, A, BERINK, P, LOPEZ-SENDON, J, TOMAN, J, CHARLESWORTH, A, ANDERS, R. J
Published in Circulation (New York, N.Y.) (11.07.2000)

Get full text

Journal Article

Intra- and interreader reproducibility of magnetic resonance imaging for quantifying the lipid-rich necrotic core is improved with gadolinium contrast enhancement

Intra- and interreader reproducibility of magnetic resonance imaging for quantifying the lipid-rich necrotic core is improved with gadolinium contrast enhancement

by Takaya, Norihide, Cai, Jianming, Ferguson MT, Marina S., Yarnykh, Vasily L., Chu, Baocheng, Saam, Tobias, Polissar, Nayak L., Sherwood, Jane, Cury, Ricardo C., Anders, Robert J., Broschat, Kay O., Hinton, Denise, Furie, Karen L., Hatsukami, Thomas S., Yuan, Chun
Published in Journal of magnetic resonance imaging (01.07.2006)

Get full text

Journal Article

Baseline characteristics and early blood pressure control in the CONVINCE trial

Baseline characteristics and early blood pressure control in the CONVINCE trial

by BLACK, Henry R, ELLIOTT, William J, WEBER, Michael A, WHITE, William B, WILLIAMS, Gordon, WITTES, Janet, ZANCHETTI, Alberto, FAKOUHI, T. Daniel, ANDERS, Robert J, NEATON, James D, GRANDITS, Gregory, GRAMBSCH, Patricia, GRIMM, Richard H, HANSSON, Lennart, LACOUCIERE, Yves, MULLER, James, SLEIGHT, Peter
Published in Hypertension (Dallas, Tex. 1979) (2001)

Get full text

Journal Article

Placebo-controlled evaluation of three doses of a controlled-onset, extended-release formulation of verapamil in the treatment of stable angina pectoris

Placebo-controlled evaluation of three doses of a controlled-onset, extended-release formulation of verapamil in the treatment of stable angina pectoris

by Cutler, Neal R., Anders, Robert J., Jhee, Stanford S., Sramek, John J., Awan, Najam A., Bultas, Jan, Lahiri, Avijit, Woroszylska, Marynika
Published in The American journal of cardiology (01.06.1995)

Get full text

Journal Article

Preventing increases in early-morning blood pressure, heart rate, and the rate-pressure product with controlled onset extended release verapamil of bedtime versus enalapril, losartan, and placebo on arising

Preventing increases in early-morning blood pressure, heart rate, and the rate-pressure product with controlled onset extended release verapamil of bedtime versus enalapril, losartan, and placebo on arising

by WHITE, William B, SICA, Domenic A, CALHOUN, David, MANSOOR, George A, ANDERS, Robert J
Published in The American heart journal (01.10.2002)

Get full text

Journal Article

Preventing increases in early-morning blood pressure, heart rate, and the rate-pressure product with controlled onset extended release verapamil at bedtime versus enalapril, losartan, and placebo on arising

Preventing increases in early-morning blood pressure, heart rate, and the rate-pressure product with controlled onset extended release verapamil at bedtime versus enalapril, losartan, and placebo on arising

by White, William B., Sica, Domenic A., Calhoun, David, Mansoor, George A., Anders, Robert J.
Published in The American heart journal (01.10.2002)

Get full text

Journal Article

Results of the Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) trial by geographical region

Results of the Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) trial by geographical region

by Black, Henry R, Elliott, William J, Grandits, Gregory, Grambsch, Patricia, Lucente, Tracy, Neaton, James D, Grimm, Jr, Richard H, Hansson, Lennart, Lacourcière, Yves, Muller, James E, Sleight, Peter, Weber, Michael A, White, William B, Williams, Gordon H, Wittes, Janet, Zanchetti, Alberto, Anders, Robert J
Published in Journal of hypertension (01.05.2005)

Get more information

Journal Article

Pharmacodynamic efficacy, clinical safety, and outcomes after prolonged platelet glycoprotein IIb/IIIa Receptor Blockade with oral xemilofiban: Results of a multicenter, placebo-controlled, randomized Trial

Pharmacodynamic efficacy, clinical safety, and outcomes after prolonged platelet glycoprotein IIb/IIIa Receptor Blockade with oral xemilofiban: Results of a multicenter, placebo-controlled, randomized Trial

by KEREIAKES, D. J, KLEIMAN, N. S, HANTSBARGER, G. L, BRYZINSKI, B, TOPOL, E. J, FERGUSON, J. J, ZAKI MASUD, A. R, BRODERICK, T. M, ABBOTTSMITH, C. W, RUNYON, J. P, ANDERSON, L. C, ANDERS, R. J, DREILING, R. J
Published in Circulation (New York, N.Y.) (29.09.1998)

Get full text

Journal Article

First chronic platelet glycoprotein IIb/IIIa integrin blockade : A randomized, placebo-controlled pilot study of Xemilofiban in unstable angina with percutaneous coronary interventions

First chronic platelet glycoprotein IIb/IIIa integrin blockade : A randomized, placebo-controlled pilot study of Xemilofiban in unstable angina with percutaneous coronary interventions

by SIMPFENDORFER, C, KOTTKE-MARCHANT, K, RAYMOND, R. E, SUTTON, J. M, TOPOL, E. J, LOWRIE, M, ANDERS, R. J, BURNS, D. M, MILLER, D. P, COVE, C. S, DEFRANCO, A. C, ELLIS, S. G, MOLITERNO, D. J
Published in Circulation (New York, N.Y.) (01.07.1997)

Get full text

Journal Article

A comparative trial of controlled-onset, extended-release verapamil, enalapril, and losartan on blood pressure and heart rate changes

A comparative trial of controlled-onset, extended-release verapamil, enalapril, and losartan on blood pressure and heart rate changes

by Bakris, George, Sica, Dominic, Ram, Venkata, Fagan, Timothy, Vaitkus, Paul T, Anders, Robert J
Published in American journal of hypertension (2002)

Get full text

Journal Article

Sustained platelet glycoprotein IIb/IIIa blockade with oral xemilofiban in 170 patients after coronary stent deployment

Sustained platelet glycoprotein IIb/IIIa blockade with oral xemilofiban in 170 patients after coronary stent deployment

by KEREIAKES, D. J, KLEIMAN, N, FERGUSON, J. J, RUNYON, J. P, BRODERICK, T. M, HIGBY, N. A, MARTIN, L. H, HANTSBARGER, G, MCDONALD, S, ANDERS, R. J
Published in Circulation (New York, N.Y.) (19.08.1997)

Get full text

Journal Article

Safety of controlled-onset extended-release verapamil in middle-aged and older patients with hypertension and coronary artery disease

Safety of controlled-onset extended-release verapamil in middle-aged and older patients with hypertension and coronary artery disease

by White, William B., Johnson, Mary F., Anders, Robert J., Elliott, William J., Black, Henry R.
Published in The American heart journal (01.12.2001)

Get full text

Journal Article

P-392: Circadian variation in cardiovascular events among diabetics in the convince trial

P-392: Circadian variation in cardiovascular events among diabetics in the convince trial

by Black, Henry R., Elliott, William J., Grandits, Gregory, Grambsch, Patricia, Neaton, James D., White, William B., Anders, Robert J.
Published in American journal of hypertension (01.05.2004)

Get full text

Journal Article

P-391: Factors in the choice of beta-blocker vs. diuretic for initial treatment of hypertension in convince

P-391: Factors in the choice of beta-blocker vs. diuretic for initial treatment of hypertension in convince

by Black, Henry R., Elliott, William J., Grandits, Gregory, Grambsch, Patricia, Neaton, James D., Sleight, Peter, White, William B., Zanchetti, Alberto, Anders, Robert J.
Published in American journal of hypertension (01.05.2004)

Get full text

Journal Article

P-395: Outcomes with physician's choice of initial drug in convince

P-395: Outcomes with physician's choice of initial drug in convince

by Black, Henry R., Elliott, William J., Grandits, Gregory, Grambsch, Patricia, Neaton, James D., Sleight, Peter, White, William B., Zanchetti, Alberto, Anders, Robert J.
Published in American journal of hypertension (01.05.2004)

Get full text

Journal Article

P-394: Predictors of blood pressure control in the convince trial

P-394: Predictors of blood pressure control in the convince trial

by Black, Henry R., Elliott, William J., Grandits, Gregory, Grambsch, Patricia, Neaton, James D., Sleight, Peter, White, William B., Zanchetti, Alberto, Anders, Robert J.
Published in American journal of hypertension (01.05.2004)

Get full text

Journal Article

Differential dose-response to oral xemilofiban after antecedent intravenous abciximab : Administration for complex coronary intervention

Differential dose-response to oral xemilofiban after antecedent intravenous abciximab : Administration for complex coronary intervention

by KEREIAKES, D. J, RUNYON, J. P, KLEIMAN, N. S, HIGBY, N. A, ANDERSON, L. C, HANTSBARGER, G, MCDONALD, S, ANDERS, R. J
Published in Circulation (New York, N.Y.) (01.09.1996)

Get full text

Journal Article

P-414: Predictors of “lost-to-follow-up” status in the convince trial

P-414: Predictors of “lost-to-follow-up” status in the convince trial

by Black, Henry R., Elliott, William J., Grambsch, Patricia M., Li, Bing B., Wu, Xiaoting, Grandits, Gregory, Neaton, James D., Anders, Robert J.
Published in American journal of hypertension (01.05.2003)

Get full text

Journal Article

Orbofiban: An orally active GPIIb/IIIa platelet receptor antagonist

Orbofiban: An orally active GPIIb/IIIa platelet receptor antagonist

by Nicholson, Nancy S., Abood, Norman A., Panzer-Knodle, Susan G., Frederick, Leo G., Page, Jimmy D., Salyers, Anita K., Suleymanov, Osman D., Szalony, James A., Taite, Beatrice B., Anders, Robert J.
Published in Medicinal research reviews (01.05.2001)

Get full text

Journal Article